Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lord Abbett Developing Growth Fund Class A (LAGWX)

Net Asset Value
1 Day
Overall Morningstar Rating
Small growth
Style or Category
Sales Expenses
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital through a diversified and actively managed portfolio consisting of developing growth companies- many of which are traded over the counter. To pursue its objective- the fund invests primarily in the equity securities of companies the portfolio management team believes demonstrate above-average- long-term growth potential. It invests at least 65% of its net assets in equity securities of small companies. The fund may invest up to 10% of its net assets in foreign companies- including emerging market companies and American Depositary Receipts ("ADRs").


1 month+2.89% 3 years+6.68%
3 months+9.24% 5 years+12.81%
1 year+28.53% Since inception+10.52%
Data through --

Peer Comparisonvs. Small growth

Performance 5-yr return+12.81%+13.96%
Expense ratio0.96%1.28%
Risk 5 year sharpe ratio0.851.01
Net assets$1.9B$1.0B
Average market cap$3.4B$3.8B
Average P/E30.228.5
Portfolio turnover134%134%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyLord Abbett
Fund manager & tenureF. O’Halloran / 16 Years
Minimal initial investment$1,000.00
Minimum IRA investment$1,000.00


U.S. stock95.05%
International stock4.95%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 15.78%
Industrial materials 12.87%
Hardware 10.98%
Consumer goods 9.38%
Business service 9.03%
Top 10 Holdings
Portfolio weighting
PLNT Planet Fitness Inc2.73%
PODD Insulet Corp2.46%
TWOU 2U Inc2.33%
GRUB GrubHub Inc1.99%
LYV Live Nation Entertainment Inc1.94%
EXAS Exact Sciences Corp1.91%
PEN Penumbra Inc1.91%
OLED Universal Display Corp1.87%
BPMC Blueprint Medicines Corp1.81%
HUBS HubSpot Inc1.77%